Summary
This study elucidates a molecular pathway linking neuroinflammation to neurodegeneration in multiple sclerosis through STING-mediated ferroptosis. The authors demonstrate that glutamate excitotoxicity-induced detachment of STING from STIM1 triggers non-canonical STING signalling, leading to autophagic GPX4 degradation and neuronal ferroptotic cell death. STING inhibition—both genetic and pharmacological—protects neurons, positioning STING as a potential therapeutic target for MS-associated neurodegeneration.
Regional applicability
This is a mechanistic cell and molecular biology study conducted in laboratory and mouse model systems; its geographical setting is not specified from the metadata, but findings on STING signalling are likely applicable across MS populations globally, subject to validation in clinical trials. Therapeutic targeting of STING may have relevance to MS management in the United Kingdom and elsewhere, pending human translation.
Key measures
STING activation, STIM1–STING interaction, GPX4 levels, ferroptosis markers, neurodegeneration endpoints in MS mouse model
Outcomes reported
The study identified STING as a central regulator of neuronal inflammatory stress response in multiple sclerosis, showing that STING activation via STIM1 detachment triggers ferroptosis through GPX4 degradation. Both genetic and pharmacological STING inhibition protected against inflammation-induced neurodegeneration in mouse models and human MS tissue.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.